Pandemic influenza A 2009 (H1N1)
Conditions
Interventions
Subcutaneus injection of 15 &
micro
g of hemagglutinin antigen dose of monovalent, unadjuvanted 2009 influenza A(H1N1) vaccine in a 1-dose regimen.
Sponsors
The Tazuke Kofukai Medical Research Institute
Osaka Prefectural Institute of Health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Pediatrician working in Kitano Hospital
Exclusion criteria
Exclusion criteria: excluding the above-mentioned
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the immunogenicity of a 2009 influenza A(H1N1) vaccine in health care workers. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety of a 2009 influenza A(H1N1) vaccine in health care workers. | — |
Countries
Japan
Outcome results
None listed